
Sign up to save your podcasts
Or


Send us Fan Mail
This episode is hoping to show patients and the public that non-smoking lung cancer is a very real and very different type of lung cancer to smoking lung cancer.
We discuss the great work that charities like Ruth Strauss foundation, Ros Wonders and EGFR UK do to support this patient group.
Pollution may play a part, vaping may play a part.
Dr Tom Newsom-Davis Chair-elect of the British Thoracic Oncology Group shines a light on this area of lung cancer.
Send us Fan Mail
Radiotherapy is one of the silent workhorses of cancer treatment yet has very little coverage in the media.
In this episode we talk to Amy Warnock one of our treatment radiographers about what to expect during radiotherapy and she talks through what will happen on the day to day basis of radiotherapy.
We hope you enjoy.
John & Mike
Send us Fan Mail
Chemotherapy is scary and we want to make it less scary for patients. Simple.
We talk to senior chemotherapy nurse Rachel Bryce from University Hospital Plymouth - she is also Macmillan lead systemic anti-cancer therapy (SACT) lead and UKONS SACT representative - about what patients can expect and what to look out for expect on chemotherapy.
We think this is great discussion that could be used for anyone new to or dealing with chemotherapy.
We hope you enjoy.
John & Mike
Send us Fan Mail
In recent years we have seen a marked change in the landscape of treatment for endometrial cancer.
This has been driven by understanding the different molecular subtypes of endometrial cancer.
POLE - with an excellent prognosis
MMR deficient - with good prognosis and option for immunotherapy
No Specific molecular profile - intermediate outcome and work still to be done
P53 mutant - with a poorer outcome
Dr Angela George from the Royal Marsden Hospital has a specialist interest in genomics and shares her expertise and knowledge on this fascinating area of gynaecological cancers.
Send us Fan Mail
Approximately 1 in 10 metastatic prostate cancer patients develop osteoporotic fractures.
Whilst treatment for prostate cancer has meant patient are living longer we have to make sure they are also living better.
Testosterone removal, Androgen receptor targeted agents and steroids can all reduce bone strength.
We talk to Dr Xue-Yan Jiang who is part of a group preparing guidelines for bone health through the Royal College of Radiologists and British Association of Urological Surgeons.
We hope you enjoy.
Send us Fan Mail
Approximately 15% of all lung cancer happen in non-smokers!!
We talk to Dr Tom Newsom-Davis a medical oncologist who specialises in lung cancer about this very specific group of lung cancers.
Tom is chair-elect of the British Thoracic Oncology Group and shares his experience of treating non-smoking related lung cancers and their driver mutations - EGFR, ROS-1 and ALK.
This is a fascinating discussion and Tom is such an engaging person to talk to.
If you have lungs you can get lung cancer.
Enjoy
John & Mike
Send us Fan Mail
In this episode we discuss CDK4/6 inhibitors with Professor Mark Beresford, Clinical oncologist and chair of UK Breast cancer Group.
Mark shares his knowledge on why we are giving these drugs to patients with breast cancer and what patients can expect on them.
This is a really big group of patients and we hope this is useful for supporting them.
We hope you enjoy
John & Mike
Send us Fan Mail
To day we focus on the big 3 side effects of hormone manipulation in prostate cancer:
-Hot Flushes
-The 5 Ps of Fatigue
-Sexual Function
We talk to British Association or Urological Nursing trustee and nurse specialist Debbie Victor on strategies to manage these side effects.
This is aimed at helping patients help themselves so feel free to share with anyone you know having hormone therapy for prostate cancer.
We hope this is useful.
John & Mike
Send us Fan Mail
Hormone therapy is a key part of prostate cancer treatment. Removing access to testosterone starves prostate cancer and can cause a 'manopause' or male menopause symptoms.
We discuss this with clinical nurse and BAUN trustee- Debbie Victor.
We look at the impact of this on prostate cancer patients and what positive steps patients can take to tackle these side effects themselves.
We hope you enjoy.
Mike & John
Send us Fan Mail
Dr Nicolo Battisti is the president of the Society of international geriatric oncology and a medical oncologist at the Royal Marsden Hospital.
He shares his thoughts and wisdom on how we can help our older patients and their carers recognise signs of frailty and how to tackle them.
From the publisher's feed
Welcome to Simply Oncology.
Cancer is daunting for both patients and for clinical teams.
Dr John McGrane and Dr Michael Rowe are oncologists who want to break down the complex parts of…